These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25242303)

  • 1. Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice.
    Qin W; Akutsu Y; Andocs G; Suganami A; Hu X; Yusup G; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Isozaki Y; Akanuma N; Tamura Y; Matsubara H
    Oncol Rep; 2014 Dec; 32(6):2373-9. PubMed ID: 25242303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
    Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
    Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
    Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
    BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of hyperthermia and dendritic cell immunotherapy for squamous cell carcinoma.
    Matsumoto K; Yamamoto N; Hagiwara S; Saito M; Furue H; Shigetomi T; Narita Y; Mitsudo K; Tohnai I; Kobayashi T; Ueda M
    Oncol Rep; 2011 Jun; 25(6):1525-32. PubMed ID: 21455579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
    O-Sullivan I; Kim TS; Chopra A; Cohen EP
    Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
    BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.
    Ahmed SU; Okamoto M; Oshikawa T; Tano T; Sasai A; Kan S; Hiroshima T; Ohue H; Moriya Y; Ryoma Y; Saito M; Sato M
    J Immunother; 2004; 27(6):432-41. PubMed ID: 15534487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulated Electro-Hyperthermia-Induced Tumor Damage Mechanisms Revealed in Cancer Models.
    Krenacs T; Meggyeshazi N; Forika G; Kiss E; Hamar P; Szekely T; Vancsik T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with dendritic cells in an animal model of early pulmonary metastatic squamous cell carcinoma.
    Moon JH; Chung MK; Son YI
    Laryngoscope; 2012 Nov; 122(11):2442-6. PubMed ID: 22926978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.
    Moyer JS; Li J; Wei S; Teitz-Tennenbaum S; Chang AE
    J Immunother; 2008; 31(9):885-95. PubMed ID: 18832999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
    Viana PHL; Schvarcz CA; Danics LO; Besztercei B; Aloss K; Bokhari SMZ; Giunashvili N; Bócsi D; Koós Z; Benyó Z; Hamar P
    Sci Rep; 2024 Apr; 14(1):8241. PubMed ID: 38589452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
    Mukhopadhaya A; Mendecki J; Dong X; Liu L; Kalnicki S; Garg M; Alfieri A; Guha C
    Cancer Res; 2007 Aug; 67(16):7798-806. PubMed ID: 17699785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma.
    Matsunaga A; Ueda Y; Yamada S; Harada Y; Shimada H; Hasegawa M; Tsujii H; Ochiai T; Yonemitsu Y
    Cancer; 2010 Aug; 116(15):3740-8. PubMed ID: 20564091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.